Authors: Lauria, R

Citation: R. Lauria, In answer to a quasi-ontological argument: On Sheridan's "toward an eclectic ontology of presence" and Mantovani and Riva's "building a bridge between different scientific communities", PRESENCE-T, 10(5), 2001, pp. 557-563

Authors: De Placido, S Tramontana, S Ferrari, E De Matteis, A Lauria, R Perrone, F Bianco, AR Gallo, C Ricchi, P De Placido, G Pignata, S

Citation: S. De Placido et al., Carboplatin, cisplatin and paclitaxel in the treatment of patients with epithelial ovarian cancer, ANTICANC R, 20(5C), 2000, pp. 4023-4029

Authors: De Placido, S Lauria, R Perrone, F Lombardi, AV Carlomagno, C Varriale, E Costanzo, R Leo, L De Laurentiis, M Bianco, AR

Citation: S. De Placido et al., Vinorelbine plus mitomycin C as second-line treatment of metastatic breastcancer: A two-stage phase 2 study, ONCOL-BASEL, 58(1), 2000, pp. 8-14

Authors: De Placido, S Lauria, R Carlomagno, C Perrone, F De Laurentiis, M Gallo, C Martignetti, A Bellelli, T Limite, G Petrella, G Bianco, AR

Citation: S. De Placido et al., The impact of schedule on acute toxicity and dose-intensity of high-dose chemotherapy with epirubicin and cyclophosphamide plus colony stimulating factors in advanced breast cancer, INT J ONCOL, 15(2), 1999, pp. 339-346

Authors: Lauria, R Ferrari, E Tramontana, S Morabito, A Perrone, F Maffeo, A Fiorentino, R Casella, G Iodice, F Ricchi, P Carlomagno, C Varriale, E De Placido, G De Placido, S Bianco, AR Pignata, S

Citation: R. Lauria et al., A phase I study of paclitaxel and epirubicin, without and with filgrastim,for the treatment of platinum-resistant advanced ovarian cancer, ONCOL-BASEL, 56(4), 1999, pp. 267-273